Loading…

The role of thrombin receptors PAR1 and PAR4 for PAI-1 storage, synthesis and secretion by human platelets

Abstract Introduction Arterial thrombi contain more platelets than venous thrombi and are more resistant to fibrinolysis. This resistance could partly be due to plasminogen activator inhibitor 1 (PAI-1) secreted by platelets. The aim of this study was to elucidate differences between thrombin recept...

Full description

Saved in:
Bibliographic Details
Published in:Thrombosis research 2012-04, Vol.129 (4), p.e51-e58
Main Authors: Nylander, Martina, Osman, Abdimajid, Ramström, Sofia, Åklint, Emma, Larsson, Anders, Lindahl, Tomas L
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c533t-b9029ec3e8cfc634181fa527dd265c0007bf0f2ca87bd0c29b395c64e0ea856a3
cites cdi_FETCH-LOGICAL-c533t-b9029ec3e8cfc634181fa527dd265c0007bf0f2ca87bd0c29b395c64e0ea856a3
container_end_page e58
container_issue 4
container_start_page e51
container_title Thrombosis research
container_volume 129
creator Nylander, Martina
Osman, Abdimajid
Ramström, Sofia
Åklint, Emma
Larsson, Anders
Lindahl, Tomas L
description Abstract Introduction Arterial thrombi contain more platelets than venous thrombi and are more resistant to fibrinolysis. This resistance could partly be due to plasminogen activator inhibitor 1 (PAI-1) secreted by platelets. The aim of this study was to elucidate differences between thrombin receptors protease-activated receptor (PAR) 1 and 4 and platelet storage, secretion and synthesis of platelet PAI-1, as compared to other platelet α-granule proteins such as VEGF and endostatin. Materials and methods Human isolated platelets were incubated with thrombin (0.5 U/ml), PAR1-activating peptide (AP) (0.4-30 μM) or PAR4-AP (1.5-300 μM) for up to 24 hours. ELISA, western blot and fluorescence microscopy were used to measure secretion, contents and localization of PAI-1, VEGF and endostatin. Results Our results show that PAI-1 and VEGF might be co-localized and that endostatin does not co-localize with either PAI-1 or VEGF. PAI-1 and VEGF show a similar secretion pattern, being more sensitive to low grade PAR1 activation, but secretion was also observed with higher concentrations of PAR4-APs. PAI-1 is secreted in an active form. PAI-1 mRNA was found in platelets, and elevated levels of PAI-1 were detected after 24 hours incubation of platelets. Conclusions PAI-1 and VEGF, but not endostatin, might be stored in the same α-granule in human platelets. PAI-1 and VEGF also show a similar secretion pattern, being more sensitive to PAR1 than to PAR4 activation, but the secretion is not exclusively selective. Our results also show that platelet PAI-1 is increased if incubated for 24 hours, both with addition of PAR1-activating peptide and without activation, which could indicate de novo synthesis.
doi_str_mv 10.1016/j.thromres.2011.12.021
format article
fullrecord <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_DiVA_org_uu_168691</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0049384811006864</els_id><sourcerecordid>929123035</sourcerecordid><originalsourceid>FETCH-LOGICAL-c533t-b9029ec3e8cfc634181fa527dd265c0007bf0f2ca87bd0c29b395c64e0ea856a3</originalsourceid><addsrcrecordid>eNqNksFu1DAQhiMEotvCK1S-cWkWj5048QWxKhQqVQJB4TpynEnXSzZO7QS0b4-32_bAhZ48kr_5R5pvsuwU-BI4qLeb5bQOfhsoLgUHWIJYcgHPsgXUlc5FUYnn2YLzQueyLuqj7DjGDedQgS5fZkdCiFrqqlhkm-s1seB7Yr5jd5GNG1ggS-PkQ2RfV9-AmaHdFwXrfEjFZQ4spl9zQ2cs7oZpTdHFOyqSDTQ5P7Bmx9bz1gxs7M1EPU3xVfaiM32k1_fvSfbj4uP1-ef86suny_PVVW5LKae80VxospJq21klC6ihM6Wo2lao0nLOq6bjnbCmrpqWW6EbqUurCuJk6lIZeZKdHXLjHxrnBsfgtibs0BuHH9zPFfpwg_OMoGql4Wm4DzMqBeqJeO9mrEBqmfA3B3wM_namOOHWRUt9bwbyc0QtNAjJZZlIdSBt8DEG6h6jgePeOW7wwTnunSMITM5T4-n9iLnZUvvY9iA5Ae8PAKWt_3YUMFpHg6XWJdETtt79f8a7fyJs7wZnTf-LdhQ3fg5DcoqAMTXg9_3l7Q8PgPO05kL-BUbC1i0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>929123035</pqid></control><display><type>article</type><title>The role of thrombin receptors PAR1 and PAR4 for PAI-1 storage, synthesis and secretion by human platelets</title><source>Elsevier</source><creator>Nylander, Martina ; Osman, Abdimajid ; Ramström, Sofia ; Åklint, Emma ; Larsson, Anders ; Lindahl, Tomas L</creator><creatorcontrib>Nylander, Martina ; Osman, Abdimajid ; Ramström, Sofia ; Åklint, Emma ; Larsson, Anders ; Lindahl, Tomas L</creatorcontrib><description>Abstract Introduction Arterial thrombi contain more platelets than venous thrombi and are more resistant to fibrinolysis. This resistance could partly be due to plasminogen activator inhibitor 1 (PAI-1) secreted by platelets. The aim of this study was to elucidate differences between thrombin receptors protease-activated receptor (PAR) 1 and 4 and platelet storage, secretion and synthesis of platelet PAI-1, as compared to other platelet α-granule proteins such as VEGF and endostatin. Materials and methods Human isolated platelets were incubated with thrombin (0.5 U/ml), PAR1-activating peptide (AP) (0.4-30 μM) or PAR4-AP (1.5-300 μM) for up to 24 hours. ELISA, western blot and fluorescence microscopy were used to measure secretion, contents and localization of PAI-1, VEGF and endostatin. Results Our results show that PAI-1 and VEGF might be co-localized and that endostatin does not co-localize with either PAI-1 or VEGF. PAI-1 and VEGF show a similar secretion pattern, being more sensitive to low grade PAR1 activation, but secretion was also observed with higher concentrations of PAR4-APs. PAI-1 is secreted in an active form. PAI-1 mRNA was found in platelets, and elevated levels of PAI-1 were detected after 24 hours incubation of platelets. Conclusions PAI-1 and VEGF, but not endostatin, might be stored in the same α-granule in human platelets. PAI-1 and VEGF also show a similar secretion pattern, being more sensitive to PAR1 than to PAR4 activation, but the secretion is not exclusively selective. Our results also show that platelet PAI-1 is increased if incubated for 24 hours, both with addition of PAR1-activating peptide and without activation, which could indicate de novo synthesis.</description><identifier>ISSN: 0049-3848</identifier><identifier>ISSN: 1879-2472</identifier><identifier>EISSN: 1879-2472</identifier><identifier>DOI: 10.1016/j.thromres.2011.12.021</identifier><identifier>PMID: 22283974</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Blood Platelets ; Blood Platelets - metabolism ; Cells, Cultured ; Endostatins - metabolism ; Hematology, Oncology and Palliative Medicine ; Humans ; MEDICIN ; MEDICINE ; PAR1 ; PAR4 ; Plasminogen Activator Inhibitor 1 ; Plasminogen Activator Inhibitor 1 - metabolism ; Receptor, PAR-1 - metabolism ; Receptors, Thrombin - metabolism ; Thrombin ; Thrombin - pharmacokinetics ; VEGF</subject><ispartof>Thrombosis research, 2012-04, Vol.129 (4), p.e51-e58</ispartof><rights>Elsevier Ltd</rights><rights>2012 Elsevier Ltd</rights><rights>Copyright © 2012 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c533t-b9029ec3e8cfc634181fa527dd265c0007bf0f2ca87bd0c29b395c64e0ea856a3</citedby><cites>FETCH-LOGICAL-c533t-b9029ec3e8cfc634181fa527dd265c0007bf0f2ca87bd0c29b395c64e0ea856a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22283974$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-71393$$DView record from Swedish Publication Index$$Hfree_for_read</backlink><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-66161$$DView record from Swedish Publication Index$$Hfree_for_read</backlink><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-168691$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Nylander, Martina</creatorcontrib><creatorcontrib>Osman, Abdimajid</creatorcontrib><creatorcontrib>Ramström, Sofia</creatorcontrib><creatorcontrib>Åklint, Emma</creatorcontrib><creatorcontrib>Larsson, Anders</creatorcontrib><creatorcontrib>Lindahl, Tomas L</creatorcontrib><title>The role of thrombin receptors PAR1 and PAR4 for PAI-1 storage, synthesis and secretion by human platelets</title><title>Thrombosis research</title><addtitle>Thromb Res</addtitle><description>Abstract Introduction Arterial thrombi contain more platelets than venous thrombi and are more resistant to fibrinolysis. This resistance could partly be due to plasminogen activator inhibitor 1 (PAI-1) secreted by platelets. The aim of this study was to elucidate differences between thrombin receptors protease-activated receptor (PAR) 1 and 4 and platelet storage, secretion and synthesis of platelet PAI-1, as compared to other platelet α-granule proteins such as VEGF and endostatin. Materials and methods Human isolated platelets were incubated with thrombin (0.5 U/ml), PAR1-activating peptide (AP) (0.4-30 μM) or PAR4-AP (1.5-300 μM) for up to 24 hours. ELISA, western blot and fluorescence microscopy were used to measure secretion, contents and localization of PAI-1, VEGF and endostatin. Results Our results show that PAI-1 and VEGF might be co-localized and that endostatin does not co-localize with either PAI-1 or VEGF. PAI-1 and VEGF show a similar secretion pattern, being more sensitive to low grade PAR1 activation, but secretion was also observed with higher concentrations of PAR4-APs. PAI-1 is secreted in an active form. PAI-1 mRNA was found in platelets, and elevated levels of PAI-1 were detected after 24 hours incubation of platelets. Conclusions PAI-1 and VEGF, but not endostatin, might be stored in the same α-granule in human platelets. PAI-1 and VEGF also show a similar secretion pattern, being more sensitive to PAR1 than to PAR4 activation, but the secretion is not exclusively selective. Our results also show that platelet PAI-1 is increased if incubated for 24 hours, both with addition of PAR1-activating peptide and without activation, which could indicate de novo synthesis.</description><subject>Blood Platelets</subject><subject>Blood Platelets - metabolism</subject><subject>Cells, Cultured</subject><subject>Endostatins - metabolism</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>MEDICIN</subject><subject>MEDICINE</subject><subject>PAR1</subject><subject>PAR4</subject><subject>Plasminogen Activator Inhibitor 1</subject><subject>Plasminogen Activator Inhibitor 1 - metabolism</subject><subject>Receptor, PAR-1 - metabolism</subject><subject>Receptors, Thrombin - metabolism</subject><subject>Thrombin</subject><subject>Thrombin - pharmacokinetics</subject><subject>VEGF</subject><issn>0049-3848</issn><issn>1879-2472</issn><issn>1879-2472</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNqNksFu1DAQhiMEotvCK1S-cWkWj5048QWxKhQqVQJB4TpynEnXSzZO7QS0b4-32_bAhZ48kr_5R5pvsuwU-BI4qLeb5bQOfhsoLgUHWIJYcgHPsgXUlc5FUYnn2YLzQueyLuqj7DjGDedQgS5fZkdCiFrqqlhkm-s1seB7Yr5jd5GNG1ggS-PkQ2RfV9-AmaHdFwXrfEjFZQ4spl9zQ2cs7oZpTdHFOyqSDTQ5P7Bmx9bz1gxs7M1EPU3xVfaiM32k1_fvSfbj4uP1-ef86suny_PVVW5LKae80VxospJq21klC6ihM6Wo2lao0nLOq6bjnbCmrpqWW6EbqUurCuJk6lIZeZKdHXLjHxrnBsfgtibs0BuHH9zPFfpwg_OMoGql4Wm4DzMqBeqJeO9mrEBqmfA3B3wM_namOOHWRUt9bwbyc0QtNAjJZZlIdSBt8DEG6h6jgePeOW7wwTnunSMITM5T4-n9iLnZUvvY9iA5Ae8PAKWt_3YUMFpHg6XWJdETtt79f8a7fyJs7wZnTf-LdhQ3fg5DcoqAMTXg9_3l7Q8PgPO05kL-BUbC1i0</recordid><startdate>20120401</startdate><enddate>20120401</enddate><creator>Nylander, Martina</creator><creator>Osman, Abdimajid</creator><creator>Ramström, Sofia</creator><creator>Åklint, Emma</creator><creator>Larsson, Anders</creator><creator>Lindahl, Tomas L</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>DG8</scope><scope>D91</scope><scope>DF2</scope></search><sort><creationdate>20120401</creationdate><title>The role of thrombin receptors PAR1 and PAR4 for PAI-1 storage, synthesis and secretion by human platelets</title><author>Nylander, Martina ; Osman, Abdimajid ; Ramström, Sofia ; Åklint, Emma ; Larsson, Anders ; Lindahl, Tomas L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c533t-b9029ec3e8cfc634181fa527dd265c0007bf0f2ca87bd0c29b395c64e0ea856a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Blood Platelets</topic><topic>Blood Platelets - metabolism</topic><topic>Cells, Cultured</topic><topic>Endostatins - metabolism</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>MEDICIN</topic><topic>MEDICINE</topic><topic>PAR1</topic><topic>PAR4</topic><topic>Plasminogen Activator Inhibitor 1</topic><topic>Plasminogen Activator Inhibitor 1 - metabolism</topic><topic>Receptor, PAR-1 - metabolism</topic><topic>Receptors, Thrombin - metabolism</topic><topic>Thrombin</topic><topic>Thrombin - pharmacokinetics</topic><topic>VEGF</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nylander, Martina</creatorcontrib><creatorcontrib>Osman, Abdimajid</creatorcontrib><creatorcontrib>Ramström, Sofia</creatorcontrib><creatorcontrib>Åklint, Emma</creatorcontrib><creatorcontrib>Larsson, Anders</creatorcontrib><creatorcontrib>Lindahl, Tomas L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Linköpings universitet</collection><collection>SWEPUB Örebro universitet</collection><collection>SWEPUB Uppsala universitet</collection><jtitle>Thrombosis research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nylander, Martina</au><au>Osman, Abdimajid</au><au>Ramström, Sofia</au><au>Åklint, Emma</au><au>Larsson, Anders</au><au>Lindahl, Tomas L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The role of thrombin receptors PAR1 and PAR4 for PAI-1 storage, synthesis and secretion by human platelets</atitle><jtitle>Thrombosis research</jtitle><addtitle>Thromb Res</addtitle><date>2012-04-01</date><risdate>2012</risdate><volume>129</volume><issue>4</issue><spage>e51</spage><epage>e58</epage><pages>e51-e58</pages><issn>0049-3848</issn><issn>1879-2472</issn><eissn>1879-2472</eissn><abstract>Abstract Introduction Arterial thrombi contain more platelets than venous thrombi and are more resistant to fibrinolysis. This resistance could partly be due to plasminogen activator inhibitor 1 (PAI-1) secreted by platelets. The aim of this study was to elucidate differences between thrombin receptors protease-activated receptor (PAR) 1 and 4 and platelet storage, secretion and synthesis of platelet PAI-1, as compared to other platelet α-granule proteins such as VEGF and endostatin. Materials and methods Human isolated platelets were incubated with thrombin (0.5 U/ml), PAR1-activating peptide (AP) (0.4-30 μM) or PAR4-AP (1.5-300 μM) for up to 24 hours. ELISA, western blot and fluorescence microscopy were used to measure secretion, contents and localization of PAI-1, VEGF and endostatin. Results Our results show that PAI-1 and VEGF might be co-localized and that endostatin does not co-localize with either PAI-1 or VEGF. PAI-1 and VEGF show a similar secretion pattern, being more sensitive to low grade PAR1 activation, but secretion was also observed with higher concentrations of PAR4-APs. PAI-1 is secreted in an active form. PAI-1 mRNA was found in platelets, and elevated levels of PAI-1 were detected after 24 hours incubation of platelets. Conclusions PAI-1 and VEGF, but not endostatin, might be stored in the same α-granule in human platelets. PAI-1 and VEGF also show a similar secretion pattern, being more sensitive to PAR1 than to PAR4 activation, but the secretion is not exclusively selective. Our results also show that platelet PAI-1 is increased if incubated for 24 hours, both with addition of PAR1-activating peptide and without activation, which could indicate de novo synthesis.</abstract><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>22283974</pmid><doi>10.1016/j.thromres.2011.12.021</doi></addata></record>
fulltext fulltext
identifier ISSN: 0049-3848
ispartof Thrombosis research, 2012-04, Vol.129 (4), p.e51-e58
issn 0049-3848
1879-2472
1879-2472
language eng
recordid cdi_swepub_primary_oai_DiVA_org_uu_168691
source Elsevier
subjects Blood Platelets
Blood Platelets - metabolism
Cells, Cultured
Endostatins - metabolism
Hematology, Oncology and Palliative Medicine
Humans
MEDICIN
MEDICINE
PAR1
PAR4
Plasminogen Activator Inhibitor 1
Plasminogen Activator Inhibitor 1 - metabolism
Receptor, PAR-1 - metabolism
Receptors, Thrombin - metabolism
Thrombin
Thrombin - pharmacokinetics
VEGF
title The role of thrombin receptors PAR1 and PAR4 for PAI-1 storage, synthesis and secretion by human platelets
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T18%3A20%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20role%20of%20thrombin%20receptors%20PAR1%20and%20PAR4%20for%20PAI-1%20storage,%20synthesis%20and%20secretion%20by%20human%20platelets&rft.jtitle=Thrombosis%20research&rft.au=Nylander,%20Martina&rft.date=2012-04-01&rft.volume=129&rft.issue=4&rft.spage=e51&rft.epage=e58&rft.pages=e51-e58&rft.issn=0049-3848&rft.eissn=1879-2472&rft_id=info:doi/10.1016/j.thromres.2011.12.021&rft_dat=%3Cproquest_swepu%3E929123035%3C/proquest_swepu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c533t-b9029ec3e8cfc634181fa527dd265c0007bf0f2ca87bd0c29b395c64e0ea856a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=929123035&rft_id=info:pmid/22283974&rfr_iscdi=true